TBX21 and cervical cancer: Since the immune response in cervical cancer is predominantly characterized by Th1, Th2, Th17 and Treg cells, the contributions of the ‘T cells’ signature marker TBX21 and the ‘Th2’ signature marker IL5 were studied.